A00-B99
Conditions
Interventions
Group 1: The study is designed as an observational study (non-randomized, non-blinded). As part of the project, at least 100 seropositive and 100 seronegative healthy donors will be identified and cha
Sponsors
Universitätsklinikum Erlangen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Known positive serology for defined pathogens, if applicable. For validations, persons with HIV and pregnant women.
Exclusion criteria
Exclusion criteria: a) Persons who are unable to consent to participation themselves (e.g., due to illness or limited decision-making capacity) b) Persons who are dependent on other participants or study personnel (e.g., close professional or personal relationships) c) Children and adolescents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recruitment and serological characterization of donors for 15 pathogens; INTRA-SEQ for 15 pathogens | — |
Secondary
| Measure | Time frame |
|---|---|
| Validation and clinical testing with 150 people with HIV and 150 pregnant women | — |
Countries
Germany
Contacts
Public ContactKilian Schober
Universitätsklinikum Erlangen
Outcome results
None listed